We are live on ! Find out more
GW

GW & Wade Portfolio holdings

AUM $3.08B
1-Year Est. Return 18.99%
This Fund
S&P 500
This Quarter Est. Return
+10.47%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$2.3B
AUM Growth
+$199M
Cap. Flow
+$2.56M
Cap. Flow %
0.11%
Top 10 Hldgs %
31.22%
Holding
405
New
26
Increased
200
Reduced
114
Closed
16

Sector Composition

Rank Sector Weight
1 Miscellaneous 44.41%
2 Technology 16.22%
3 Healthcare 7.34%
4 Consumer Staples 6.16%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNQ icon
51
Vanguard Real Estate ETF
VNQ
$38.6B
$14.6M 0.63%
125,495
+71,971
+134% +$7.86M
TIP icon
52
iShares TIPS Bond ETF
TIP
$15B
$14.6M 0.63%
112,635
+14,084
+14% +$1.82M
KMB icon
53
Kimberly-Clark
KMB
$36.4B
$14M 0.61%
97,819
-208
-0.2% -$28K
XLK icon
54
State Street Technology Select Sector SPDR ETF
XLK
$121B
$13.9M 0.6%
159,720
+3,938
+3% +$324K
HD icon
55
Home Depot
HD
$329B
$13.8M 0.6%
33,313
+515
+2% +$196K
IWB icon
56
iShares Russell 1000 ETF
IWB
$49.1B
$13.3M 0.58%
50,485
-437
-0.9% -$112K
IEF icon
57
iShares 7-10 Year Treasury Bond ETF
IEF
$42.9B
$13.2M 0.57%
115,074
-3,935
-3% -$452K
IVW icon
58
iShares S&P 500 Growth ETF
IVW
$76.8B
$12.7M 0.55%
152,349
-37,800
-20% -$3.05M
MDT icon
59
Medtronic
MDT
$117B
$12.5M 0.54%
121,124
+5,183
+4% +$600K
MFC icon
60
Manulife Financial
MFC
$70.9B
$12.4M 0.54%
648,217
+5,593
+0.9% +$108K
BRK.B icon
61
Berkshire Hathaway Class B
BRK.B
$1.08T
$12.3M 0.53%
41,100
-2,608
-6% -$747K
ED icon
62
Consolidated Edison
ED
$39.8B
$11.8M 0.51%
137,861
+112,406
+442% +$8.83M
GOOGL icon
63
Alphabet (Google) Class A
GOOGL
$4.24T
$11.6M 0.51%
80,420
+2,180
+3% +$314K
IWS icon
64
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$11.4M 0.49%
93,030
+5,834
+7% +$696K
GLD icon
65
SPDR Gold Trust
GLD
$149B
$11.3M 0.49%
66,321
-461
-0.7% -$77.4K
IVE icon
66
iShares S&P 500 Value ETF
IVE
$50.2B
$10M 0.43%
63,925
-16,702
-21% -$2.54M
META icon
67
Meta Platforms (Facebook)
META
$1.47T
$9.06M 0.39%
26,952
+64
+0.2% +$21.2K
VOD icon
68
Vodafone
VOD
$37.1B
$8.49M 0.37%
569,007
-53,275
-9% -$813K
DIS icon
69
Walt Disney
DIS
$187B
$8.03M 0.35%
51,840
+363
+0.7% +$58.6K
CVX icon
70
Chevron
CVX
$396B
$7.91M 0.34%
67,422
+1,513
+2% +$172K
BSX icon
71
Boston Scientific
BSX
$67.9B
$7.8M 0.34%
183,525
-728
-0.4% -$30.6K
IEFA icon
72
iShares Core MSCI EAFE ETF
IEFA
$195B
$6.92M 0.3%
92,655
-37,913
-29% -$2.85M
VWO icon
73
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$6.59M 0.29%
133,247
+14,178
+12% +$715K
COST icon
74
Costco
COST
$419B
$6.37M 0.28%
11,222
+46
+0.4% +$23.6K
NVDA icon
75
NVIDIA
NVDA
$5.25T
$6.29M 0.27%
213,770
+14,540
+7% +$400K

Similar funds

GW & Wade's Q4 2021 Portfolio in Review

As of Q4 2021, GW & Wade held 405 positions worth $2.3B, up 9.4% from $2.11B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

GW & Wade's Q4 2021 filing shows 26 new, 200 increased, 114 reduced and 16 closed positions. Its largest new stake was Invesco FTSE RAFI Emerging Markets ETF: 63,017 shares worth $1.38M. The largest sale was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, an estimated $24.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 46% a quarter earlier, followed by Technology and Healthcare.

  • GW & Wade's largest Q4 2021 buy was Invesco FTSE RAFI Emerging Markets ETF: 63,017 shares worth $1.38M.
  • GW & Wade added most to Merck in Q4 2021, an estimated $13.3M increase.
  • GW & Wade's biggest Q4 2021 reduction was International Paper, cutting an estimated $13.4M.
  • GW & Wade fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q4 2021, selling an estimated $24.8M.
  • GW & Wade's ten largest holdings make up 31% of its $2.3B portfolio in Q4 2021.
  • GW & Wade opened 26 new positions and closed 16 in Q4 2021.
  • GW & Wade's portfolio value rose 9.4% quarter-over-quarter to $2.3B.

Based on GW & Wade's 13F filing for Q4 2021, filed 9 Feb 2022.